Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Dr Matt medical leave
View:
Post by canadafan on Jun 24, 2024 9:51am

Dr Matt medical leave

I had a feeling well over a yr ago, that Matt would be retiring 
the recent POA , was obviously part of a bigger plan
matt has not been himself last few chats etc
subtle thiings
Now, changes can & will happen
Matt if you are reading  this. All the best
we are very close to the finish line
The team in place can carry the ball across
Comment by itntdf on Jun 24, 2024 11:14am
while i can understand kirk look in the poa announcement (he has an msj law degree and is still with the company) brad doesn't have a law degree and his education is in science.  furthermore, brad was released from the company in late 2016 and his severance agreement stated: "All share awards granted to Employee under Employer’s Incentive Share Award Plan and the resolution of the ...more  
Comment by Noteable on Jun 24, 2024 11:23am
De_man  - Brad Thompson being named in the POA is self-evident and has nothing to do with what degree he holds - or not. Earlier, and on a different mesage board, you were trying to pass off your opinion that the POA appearing on file with SEC was a mistake. Well again you were wrong. 
Comment by Azzak34 on Jun 24, 2024 11:30am
That wasn't demans post Noteable, however you are spot on with the "in error" claim he made!!!! Was that a lie Deman, you can tell us all because you just got caught again!!!!! Clown. 
Comment by inthno on Jun 24, 2024 11:41am
Well u had to bring me back in again. Think what you want but the poa is a mistake and go ahead and try to ask the company yourself as they won't answer that question. But my guess is that u won't email them so I did not get caught on anything.
Comment by inthno on Jun 24, 2024 11:48am
And btw if u had looked at the document you can see that Brad did not sign it.
Comment by Noteable on Jun 24, 2024 11:54am
Defacto deemed signed on filing with the SEC.
Comment by itntdf on Jun 24, 2024 12:23pm
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by or on behalf of the following persons in the capacities indicated on June 3, 2024:   Signature   Title   /s/ Matthew Coffey   President, Chief Executive Officer and Matthew C. Coffey  ...more  
Comment by itntdf on Jun 24, 2024 12:21pm
and btw if u had looked at the document you can see there is NO signature block for brad to sign because he was appointed as attorney-in-fact for each of the officers and directors who did sign the document.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities